Intercept Pharmaceuticals: Q3 Earnings Insights


Intercept Pharmaceuticals ICPT reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Intercept Pharmaceuticals beat estimated earnings by 69.2%, reporting an EPS of $7.8 versus an estimate of $4.61.

Revenue was down $15.24 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.21 which was followed by a 13.08% increase in the share price the next day.

Here's a look at Intercept Pharmaceuticals's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.04 -0.90 -1.10 -1.09
EPS Actual -0.25 -0.58 -1.23 -0.63
Revenue Estimate 95.72M 90.49M 92.38M 83.02M
Revenue Actual 71.76M 88.58M 92.40M 92.83M

To track all earnings releases for Intercept Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!